Home
Email:
Password:
Forget your password?
Interview with Samantha Du, CEO of Hutchison Medipharma
More podcasts
Friday, July 4, 2008
Chindex recieves long-awaited SFDA approval to market two products
Free access
Thursday, July 3, 2008
China anti-doping measures stepped up ahead of Olympics
A long time coming: Bayer finalizes Topsun brand acquisition
AMDL's Jade Pharmaceutical signs LOI to acquire Sichuan drug distributor
Biofield Corp, Carelife establish healthcare JV
Wednesday, July 2, 2008
China Yongxin signs 10-year franchise agreement with US drugstore chain
Tuesday, July 1, 2008
MOH eager to extend cooperation with Japan's Astellas
China releases sub-sector pharma industry stats; rapid growth seen
Free access
Pharma moves to capture China's community healthcare market
China Biological Products gets go-ahead for new plasma collection station
Shandong Lukang Pharmaceutical to increase stake in subsidiaries
API price increases offset declining export volumes
Free access
National center for disease diagnosis and screening established in Tianjin
Sinovac begins enrollment in Phase II trial for split influenza vaccine
China's Children Pneumococcal Disease Fund established with Wyeth donation
Monday, June 30, 2008
India's Piramal Healthcare announces China acquisition intentions
China domestic biotech companies establish USD 146 million R&D fund
Aetna opens rep office in Shanghai, eyes health insurance market
Free access
Tongitang's MBO withdrawn
Free access
Under lawsuit pressure, Shanghai Worldbest pays back loan guarantor
China Construction Bank to sell off 8% of Shanghai Asia Pioneer
Shijiazhuang receives GMP for vitamin C, opens door for EU export
Friday, June 27, 2008
BMP Sunstone launches Ferriprox in China
Free access
Cuban PPG launches in China, challenges statin market?
Tsinghua University scientists develop chip to monitor cell migration
pharmaceutical,china pharmaceutical,pharm,pharmhound,generalbiologic,China drug,Drug discovery,Pharmaceutical market,China Antibody,China preclinical,China clinical trial,China CRO,China API,Matthew Chervenak,China research and development,China hepatitis,China cancer,China diabetes,China oncology,China cardiovascular,China CNS,China disease